103 related articles for article (PubMed ID: 1710992)
1. Opioid and neurokinin activities of substance P fragments and their analogs.
Lei SZ; Lipkowski AW; Wilcox GL
Eur J Pharmacol; 1991 Feb; 193(2):209-15. PubMed ID: 1710992
[TBL] [Abstract][Full Text] [Related]
2. Opioid activity of sendide, a tachykinin NK1 receptor antagonist.
Sakurada T; Yuhki M; Inoue M; Sakurada C; Tan-No K; Ohba M; Kisara K; Sakurada S
Eur J Pharmacol; 1999 Mar; 369(3):261-6. PubMed ID: 10225361
[TBL] [Abstract][Full Text] [Related]
3. Naloxone-reversible effect of spantide on the spinally mediated behavioural response induced by neurokinin-2 and -3 receptor agonists.
Sakurada T; Manome Y; Katsumata K; Uchiumi H; Tan-No K; Sakurada S; Kisara K
Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):69-75. PubMed ID: 1383832
[TBL] [Abstract][Full Text] [Related]
4. Effects of substance P and neurokinin A (substance K) on motor behavior: unique effect of substance P attributable to its amino-terminal sequence.
Hall ME; Grantham P; Limoli J; Stewart JM
Brain Res; 1987 Sep; 420(1):82-94. PubMed ID: 2445433
[TBL] [Abstract][Full Text] [Related]
5. Modulation of isolation-induced fighting by N- and C-terminal analogs of substance P: evidence for multiple recognition sites.
Hall ME; Stewart JM
Peptides; 1984; 5(1):85-9. PubMed ID: 6200867
[TBL] [Abstract][Full Text] [Related]
6. Demonstration of a 'septide-sensitive' inflammatory response in rat skin.
Ahluwalia A; Giuliani S; Maggi CA
Br J Pharmacol; 1995 Oct; 116(4):2170-4. PubMed ID: 8564245
[TBL] [Abstract][Full Text] [Related]
7. Spinal actions of GR73632, a novel tachykinin NK1 receptor agonist.
Sakurada C; Watanabe C; Inoue M; Tan-No K; Ando R; Kisara K; Sakurada T
Peptides; 1999; 20(2):301-4. PubMed ID: 10422886
[TBL] [Abstract][Full Text] [Related]
8. N-terminal substance P fragments inhibit the spinally induced, NK 1 receptor mediated behavioural responses in mice.
Sakurada T; Tan-No K; Yamada T; Sakurada S; Kisara K; Ohba M; Terenius L
Life Sci; 1990; 47(20):PL109-13. PubMed ID: 1701844
[TBL] [Abstract][Full Text] [Related]
9. Comparison of antagonistic effects of sendide and CP-96,345 on a spinally mediated behavioural response in mice.
Sakurada T; Manome Y; Katsumata K; Tan-No K; Sakurada S; Ohba M; Kisara K
Eur J Pharmacol; 1994 Aug; 261(1-2):85-90. PubMed ID: 7528145
[TBL] [Abstract][Full Text] [Related]
10. Diverse effects of tachykinins on luteinizing hormone release in male rats: mechanism of action.
Kalra PS; Sahu A; Bonavera JJ; Kalra SP
Endocrinology; 1992 Sep; 131(3):1195-201. PubMed ID: 1380435
[TBL] [Abstract][Full Text] [Related]
11. CP-96,345, which inhibits [3H] substance P binding, selectively inhibits the behavioral response to intrathecally administered N-methyl-D-aspartate, but not substance P, in the mouse.
Velázquez RA; Kitto KF; Larson AA
J Pharmacol Exp Ther; 1997 Jun; 281(3):1231-7. PubMed ID: 9190858
[TBL] [Abstract][Full Text] [Related]
12. Site-specific effects of intracerebral injections of three neurokinins (neurokinin A, neurokinin K, and neurokinin gamma) on the expression of male rat sexual behavior.
Dornan WA; Vink KL; Malen P; Short K; Struthers W; Barrett C
Physiol Behav; 1993 Aug; 54(2):249-58. PubMed ID: 7690487
[TBL] [Abstract][Full Text] [Related]
13. Studies on the vascular permeability induced by intrathecal substance P and bradykinin in the rat.
Jacques L; Couture R
Eur J Pharmacol; 1990 Aug; 184(1):9-20. PubMed ID: 1698644
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel receptor mediating substance P-induced behavior in the mouse.
Mousseau DD; Sun X; Larson AA
Eur J Pharmacol; 1992 Jul; 217(2-3):197-201. PubMed ID: 1385166
[TBL] [Abstract][Full Text] [Related]
15. Substance P(1-7) antagonizes substance P-induced aversive behaviour in mice.
Sakurada T; Kuwahara H; Takahashi K; Sakurada S; Kisara K; Terenius L
Neurosci Lett; 1988 Dec; 95(1-3):281-5. PubMed ID: 2465511
[TBL] [Abstract][Full Text] [Related]
16. A selective and extremely potent antagonist of the neurokinin-1 receptor.
Sakurada T; Manome Y; Tan-No K; Sakurada S; Kisara K; Ohba M; Terenius L
Brain Res; 1992 Oct; 593(2):319-22. PubMed ID: 1280526
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological studies of grooming and scratching behavior elicited by spinal substance P and excitatory amino acids.
Wilcox GL
Ann N Y Acad Sci; 1988; 525():228-36. PubMed ID: 2455461
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
Picard P; Regoli D; Couture R
Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
[TBL] [Abstract][Full Text] [Related]
19. Nociceptin-induced scratching, biting and licking in mice: involvement of spinal NK1 receptors.
Sakurada T; Katsuyama S; Sakurada S; Inoue M; Tan-No K; Kisara K; Sakurada C; Ueda H; Sasaki J
Br J Pharmacol; 1999 Aug; 127(7):1712-8. PubMed ID: 10455330
[TBL] [Abstract][Full Text] [Related]
20. Release of substance P by intrathecal KK-3, a newly synthesized Leu-enkephalin derivative.
Takahashi M; Tokuyama S; Kaneto H
Pharmacol Biochem Behav; 1989 Aug; 33(4):843-6. PubMed ID: 2482510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
